Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists
09/21/2010CA2387539C Method for protecting normal cells from cytotoxicity of chemotherapeutic agents
09/21/2010CA2386549C Polymorphic b form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5h-furan-2-one
09/21/2010CA2376943C Use of creatine or creatine compounds for skin preservation
09/21/2010CA2376916C Anaesthetic formulation comprising an nmda-antagonist and an alpha-2 adrenergic agonist
09/21/2010CA2367457C Protein for blocking platelet adhesion
09/21/2010CA2365890C Method for delivering benzindene prostaglandins by inhalation
09/21/2010CA2359948C Triazole compounds with dopamine-d3-receptor affinity
09/21/2010CA2345659C Biodegradable low molecular weight triblock polyester polyethylene glycol copolymers having reverse thermal gelation properties
09/21/2010CA2343074C Akt nucleic acids, polypeptides, and uses thereof
09/21/2010CA2338073C Novel urokinase inhibitors
09/21/2010CA2333947C Pyrazolopyridine compounds as adenosine a1 antagonist for male sterility
09/21/2010CA2307142C N-terminally chemically modified protein compositions and methods
09/21/2010CA2299950C Oral adhesive sheet and oral adhesive preparation
09/21/2010CA2251655C In vivo gene transfer methods for wound healing
09/21/2010CA2234941C Delivery of biologically active polypeptides
09/21/2010CA2192694C Cloning and expression of an acetylcholine-gated ion channel receptor subunit
09/20/2010CA2696705A1 New benzothiadiazepine derivatives, preparation method thereof and pharmaceutical compositions containing same
09/19/2010CA2696918A1 Compound for use in the treatment of peripheral neuropathies
09/18/2010CA2697169A1 Compositions and methods for augmenting activity of oncolytic viruses
09/16/2010WO2010105277A1 Compositions and methods for the delivery of biologically active rnas
09/16/2010WO2010105253A2 Methods and compositions for treating complications of diabetes and vascular diseases using flavones
09/16/2010WO2010105207A1 Prebiotic oligosaccharides
09/16/2010WO2010105183A1 Sphingosine kinase inhibitor prodrugs
09/16/2010WO2010105172A1 Combination therapy with thiocolchicine derivatives
09/16/2010WO2010105149A1 Ester gels, methods of manufacture, and uses thereof
09/16/2010WO2010105144A2 Method of disease-induced and receptor-mediated stem cell neuroprotection
09/16/2010WO2010105129A1 Administration of intravenous ibuprofen
09/16/2010WO2010105110A1 Pharmaceutical combinations comprising rdea119/bay 869766 for the treatment of specific cancers
09/16/2010WO2010105103A1 Compositions and methods for prophylaxis and treatment of addictions
09/16/2010WO2010105093A2 Implantable device for long-term delivery of drugs
09/16/2010WO2010105082A1 Treatment of pancreatic cancer
09/16/2010WO2010105048A1 Thiazolidinedione analogues
09/16/2010WO2010105016A1 Combination of an indazolylaminopyrrolotriazine and taxane for cancer treatment
09/16/2010WO2010105008A2 Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
09/16/2010WO2010104998A2 Methods for treating heart failure by inhibiting the mitochondrial sodium-calcium exchanger (mnce)
09/16/2010WO2010104986A1 Method for affecting the timing of cervical ripening and for parturition
09/16/2010WO2010104973A1 Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of raf kinases
09/16/2010WO2010104967A1 Sulfonamide containing compounds and uses thereof
09/16/2010WO2010104945A1 Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of raf kinases
09/16/2010WO2010104929A1 Sulfonamide containing compounds and uses thereof
09/16/2010WO2010104882A1 Methods of modulating sperm motility
09/16/2010WO2010104830A1 Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists
09/16/2010WO2010104790A2 Fatty-acid based particles
09/16/2010WO2010104721A1 Mineralocorticoid receptor antagonist and methods of use
09/16/2010WO2010104598A2 Kinase protein binding inhibitors
09/16/2010WO2010104595A1 Methods and compositions for the treatment of metabolic and cardiovascular disorders
09/16/2010WO2010104571A2 Treating chronic fatigue syndrome and prolonged qt interval
09/16/2010WO2010104563A2 Highly compactable and durable direct compression excipients and excipient systems
09/16/2010WO2010104494A1 Modified release pharmaceutical compositions of buprenorphine
09/16/2010WO2010104488A1 Novel hetero pyrrole analogs acting on cannapinoid receptors
09/16/2010WO2010104485A2 Valsartan formulations
09/16/2010WO2010104406A1 Prodrug forms of kinase inhibitors and their use in therapy
09/16/2010WO2010104394A1 Stigmasterol for the treatment of alzheimer's disease
09/16/2010WO2010104384A1 Nutritional composition inducing a postprandial endocrine response
09/16/2010WO2010104375A1 Stigmasterol for the treatment of alzheimer's disease
09/16/2010WO2010104374A1 Nutritional composition inducing a postprandial endocrine response
09/16/2010WO2010104281A2 Composition for improving atopic skin diseases
09/16/2010WO2010104205A1 7-cycloalkylaminoquinolones as gsk-3 inhibitors
09/16/2010WO2010104195A1 Novel isoindolin-1-one derivative
09/16/2010WO2010104194A1 Benzofuran derivatives
09/16/2010WO2010104187A1 Steroid compound
09/16/2010WO2010104175A1 Composition for oral administration
09/16/2010WO2010104170A1 Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
09/16/2010WO2010104147A1 Antioxidant agent
09/16/2010WO2010104093A1 Prophylactic or therapeutic agent for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivative or salt thereof as active ingredient
09/16/2010WO2010104035A1 Method for predicting therapeutic efficacy of chemotherapy on non-small-cell lung cancer
09/16/2010WO2010104024A1 Piperazine compound capable of inhibiting prostaglandin d synthase
09/16/2010WO2010104023A1 Infusion solution for administration to peripheral vein comprising carbohydrate solution having vitamin b1 contained therein stably
09/16/2010WO2010103851A1 Method for determining sensitivity to irinotecan and use thereof
09/16/2010WO2010103845A1 External preparation containing analgesic/anti-inflammatory agent
09/16/2010WO2010103844A1 External preparation containing analgesic/anti-inflammatory agent
09/16/2010WO2010103843A1 External preparation containing analgesic/anti-inflammatory agent
09/16/2010WO2010103684A1 Sequence-specific expression regulator which targets at myc downstream gene, and method for determining target or targets of myc downstream gene
09/16/2010WO2010103683A1 Topical therapeutic agent for ophthalmic diseases comprising compound capable of binding specifically to dna sequence
09/16/2010WO2010103545A2 Method of use of vitamin k as energy enhancer in diverse disease states
09/16/2010WO2010103519A1 Novel coprinus comatus and tremella mesenterica mushroom strains, products and extracts thereof and compositions comprising them
09/16/2010WO2010103486A1 Pyrazolo[1,5-a]-1,3,5-triazine derivatives, preparation thereof, and therapeutic use thereof
09/16/2010WO2010103473A1 Method of treatment of polycystic diseases and chronic lymphocytic leukemia
09/16/2010WO2010103472A1 Cosmetic use of an extract of wolfberry for treating scalp disorders
09/16/2010WO2010103438A1 Substituted indazole amides and their use as glucokinase activators
09/16/2010WO2010103437A1 Benzofuranyl derivatives used as glucokinase inhibitors
09/16/2010WO2010103429A1 1,1-(Dimethyl-Ethylamino)-2-Hydroxy-Propoxy]-Ethyl}-3-Methyl-Biphenyl-4- Carboxylic Acid Derivatives As Calcium Receptor Antagonists
09/16/2010WO2010103404A1 Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
09/16/2010WO2010103402A1 Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form and a surfactant, and methods and uses thereof
09/16/2010WO2010103381A1 Spirocyclic piperidine derivatives as trpm 8 modulators
09/16/2010WO2010103338A1 Analogues of 1,3-bis(4-nitrophenyl)triazenes, their pharmaceutically acceptable salts and n-acyl derivatives for tumour treatment
09/16/2010WO2010103335A1 Compounds for the treatment of metabolic disorders
09/16/2010WO2010103334A1 Compounds for the treatment of metabolic disorders
09/16/2010WO2010103333A1 Compounds for the treatment of metabolic disorders
09/16/2010WO2010103320A1 Use of rosuvastatin lactols as medicaments
09/16/2010WO2010103319A1 Use of atorvastatin lactols as medicaments
09/16/2010WO2010103318A1 Rosuvastatin and atorvastatin derivatives
09/16/2010WO2010103312A1 Hydroxymorpholiness and their use for the treatment of inflammatory disorders and pain
09/16/2010WO2010103306A1 Benzimidazole derivatives and their use as antivaral agents
09/16/2010WO2010103297A2 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010WO2010103283A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010WO2010103279A1 Bis aromatic compounds for use as lct4 synthase inhibitors
09/16/2010WO2010103278A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
09/16/2010WO2010103240A1 10-amino-1,2,3,4-tetrahydropyrido[2,1-a]isoindol-6(10bh)-one derivatives, method for preparing same, and therapeutic uses thereof
1 ... 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 ... 7860